The FDA has approved Zepatier for the treatment of HCV genotypes 1 and 4 infections. Zepatier has been approved by the FDA to treat hepatitis C virus genotypes 1 and 4 infections in adult patients.

In previous articles of this series, we’ve discussed several aspects of the hepatitis C virus including the nature of the infection and its distribution both globally and in the United States. Most ...

Hepatitis C is a serious blood borne disease that can cause severe liver damage and impacts over 2.5 million Americans. While the disease can be treated, treatment is not yet universally available and ...